“I was honored yesterday to be at the White House Opioid Summit on behalf of Prescient Medicine to discuss greater action in the fight against the rising tide of opioid addiction. Data has shown that there is a strong genetic component to opioid addiction, and with the right tools, an individual’s risk of opioid dependency can be predicted. We strongly believe that arming patients and physicians with predictive insight is one of the best solutions to preventing addiction and providing the information needed to make informed decisions before prescribing or taking an opioid.” 

Prescient’s LifeKit^® Predict is a validated genetic test designed to predict individual risk of opioid addiction. Using a simple cheek swab test, LifeKit^® Predict uses a person’s genes to predict opioid addiction risk. Genetic factors account for up to 75% of addiction risk, so knowing an individual's genetic risk can help patients and physicians better determine a treatment plan that’s most appropriate for that patient. Armed with the predictive insight of LifeKit^® Predict, individuals with a high risk of opioid dependency can work with their physicians to opt for alternative therapies, potentially preventing addiction before it starts. For more information, visit: http://www.prescientmedicine.com/